Records containing: Tuberculosis, Pulmonary
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2020-01-21Novel Triple-dose Tuberculosis Retreatment Regimens: How to Overcome Resistance Without Creating More
-
CLINICAL_TRIALS study record update · 2019-12-10A Pragmatic Randomised Study to Optimise Screening, Prevention and Care for Tuberculosis in Malawi
-
CLINICAL_TRIALS study record update · 2019-11-07Open-label, Randomized, Multicenter, Controlled, Parallel, Comparative Study of Efficacy and Safety of Treatment of Tuberculosis With Isoniazid, Rifampicin, Ethambutol for Intravenous Infusion in Comparison With Oral Forms While the Intensive Phase of Treatment for Patients With Widespread Destructive Pulmonary Tuberculosis With Bacterial Excretion.
-
CLINICAL_TRIALS study record update · 2019-10-25Primary Prophylaxis for Prevention of TB in Prison's Populations
-
CLINICAL_TRIALS study record update · 2019-09-06Microbiome in Patients With Pulmonary Tuberculosis, Non-tuberculous Mycobacterial Pulmonary Diseases (NTM-PD), Lung Cancer and Hemoptysis
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2019-08-30Evaluation of CRISPR-based Test for the Rapid Identification of Mycobacterium Tuberculosis Complex in Pulmonary Tuberculosis Suspects
-
CLINICAL_TRIALS study record update · 2019-06-25Clinical Analysis of the Patients With Cavitary Pulmonary Tuberculosis and Endobronchial Tuberculosis in the Private-Public Mix Project for Tuberculosis, Ulsan University Hospital Cohort (PPM-UUH Cohort)
-
CLINICAL_TRIALS study record update · 2019-05-30Study on the Management Model of "Home Treatment" for Tuberculosis Patients
-
CLINICAL_TRIALS study record update · 2019-05-07Phase I Dose Escalation Study of the Pharmacokinetics, Safety and Tolerability of Rifapentine and the Effects of Increasing Doses of Rifapentine on Induction of Metabolizing Enzymes in Healthy Volunteers
-
CLINICAL_TRIALS study record update · 2019-04-17Personalization of AntiTB Treatment: Evaluation of Pharmacological Determinants of Treatment Response
-
CLINICAL_TRIALS study record update · 2019-03-07A Randomized, Double Blind, Placebo-controlled, Single Ascending Dose Study to Evaluate Safety, Tolerability, and Pharmacokinetics of Single Doses of BTZ043 in Healthy Adult Volunteers
-
CLINICAL_TRIALS study record update · 2019-02-15An Open Label Randomized Phase 2 Clinical Trial to Assess Safety and Tolerability of RIPE vs RIPE Plus N-acetylcysteine in Patients With HIV/Aids and Pulmonary Tuberculosis
-
CLINICAL_TRIALS study record update · 2018-10-17Phase 1, Partially-Blind, Placebo Controlled Randomized, Combined SAD With Food Effect Cohort and MAD and DDI Study to Evaluate Safety, Tolerability, PK and PK Interaction Between TBA-7371 With Midazolam and Bupropion in Healthy Subjects.
-
CLINICAL_TRIALS study record update · 2018-07-13Safety, Tolerability, Pharmacokinetic Profile and Ex-vivo Antitubercular Activity of PBTZ169 Formulated as Spray- Dried Dispersion Versus Native Crystal Powder: Single Ascending Doses, Randomized, Placebo- Controlled, Cross-over Phase Ia Trial in Healthy Volunteers
-
CLINICAL_TRIALS study record update · 2018-04-24The Efficacy and Safety Evaluation of Standardized Treatment Included Rifampicin or Rifabutin in HIV/AIDs Patients Combined With Pulmonary Tuberculosis. A Prospective Study.
-
CLINICAL_TRIALS study record update · 2018-04-05Uitlity of MODS for the Diagnosis of MDR-TB and Second-Line Antituberculous Drug Susceptibility Testing in Mali
-
CLINICAL_TRIALS study record update · 2018-02-08A Phase 1, Randomized, Double-Blind, Placebo-Controlled, Single Ascending Dose Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Sutezolid in Healthy Adult Subjects
-
CLINICAL_TRIALS study record update · 2018-02-08A Multicentre Study of the Diagnostic Accuracy and Feasibility of the Xpert Ultra for Detection of TB and Rifampin Resistance in Adults Suspected of Having Pulmonary TB
-
CLINICAL_TRIALS study record update · 2017-09-20A Multiple Arm, Multiple Stage, Phase 2, OL, Randomized, Controlled Trial to Evaluate 4 Treatment Regimens of SQ109, Increased Doses of Rifampicin, and Moxifloxacin in Adults With Newly Diagnosed, Smear-positive Pulmonary Tuberculosis
-
CLINICAL_TRIALS study record update · 2017-07-21Early Diagnosis of Active Tuberculosis Using Ultra Low-dose Chest CT to Predict Progression to Active Tuberculosis Among Contacts
-
CLINICAL_TRIALS study record update · 2017-05-05Observational Study to Compare IGRA and Mantoux Test in Children With Suspected Latent or Active TB Infection
-
CLINICAL_TRIALS study record update · 2017-04-13Evaluation of 11C-acetate PET Imaging as a Novel Approach to Detecting Pathology in Pulmonary TB
-
CLINICAL_TRIALS study record update · 2017-04-04Safety and Efficacy of Blocking IL-4 With Pascolizumab in Patients Receiving Standard Combination Therapy for Pulmonary Tuberculosis (TB): a Randomized, Double-blind, Placebo-controlled, Proof-of-concept Clinical Trial
-
CLINICAL_TRIALS study record update · 2017-03-20Shortened Regimens for First Diagnosed Smear Positive Drug Susceptible Pulmonary Tuberculosis: a Randomised Controlled Non-inferiority Trial
-
CLINICAL_TRIALS study record update · 2016-11-18Evaluation of PET/MRI Using a Somatostatin Analog Tracer as a Novel Approach to Detecting Pathology in High Risk TB-exposed Contacts